32273973
2020 Mar 31
Discussing the importance of patient advocacy and the advancement of systemic therapies for the treatment of liver cancer, we catch up with Hepatic Oncology's latest editorial board member Ghassan Abou-Alfa.
advocacy; cabozantinib; hepatocellular carcinoma; systemic therapies; tyrosine kinase inhibitors.
